Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Chiral-peptide-nucleic-acid-monomers-and-oligomers

 Method for treating diseases of the inner ear using adamantane derivatives
OF THE INVENTION As already mentioned, the use of adamantane derivatives is possible or ...


 Polyalkylene oxide-containing urethane polyols with sulphonic acid groups
What is claimed is: 1. Sulphonic acid group-containing polyalkylene oxide-containing urethane ...


 Herpes treatment
I claim: 1. A method for the control of herpes virus infections in man which comprises contacting ...


 Dense star polymers and dendrimers
OF ILLUSTRATIVE EMBODIMENTS In the dense star polymers of the present invention, the core is ...


 Glycerin derivatives and inhibition of blood PAF
OF THE INVENTION The glycerine derivatives of the invention are compounds of the formula ##STR3## ...


 Oligonucleotide derivatives and production thereof
Gist In view of the state of the art as described above, the present inventors have developed an ...


 Process for synthesizing macrocyclic chelates
The invention is a process for synthesizing a 12 membered ring tetraaza macromolecule. The process ...


 Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
I claim: 1. A method for producing a 1:1 protein:anitbody tioether-linked immunoconjugate as a ...


 Compositions for photodynamic therapy
I claim: 1. A pharmaceutical composition useful for photodynamic therapy which composition contains,...


 Amplifier molecules for enhancement of diagnosis and therapy
As used herein, an "amplifier" or "amplifier molecule" is a chemical compound having a ...


 Chiral peptide nucleic acid monomers and oligomers

Details
Inventors: Nielsen, Peter; Buchardt, deceased, Ole; Buchardt, by Mrs. D.; Lagriffoul, Pierre;
Assignee:
Primary Examiner: Marschel; Ardin H.
Assistant Examiner:
Attorney, Agent or Firm: Woodcock Washburn Kurtz Mackiewicz & Norris LLP

A novel class of peptide nucleic acid monomers are synthesized having chirality in the backbone. Peptide nucleic acid oligomers are synthesized to incorporate these chiral monomers.

DETAILED DESCRIPTION What is claimed is: 1.
A peptide nucleic acid monomer having the formula: ##STR5## wherein: B is a naturally or non-naturally ocurring nucleobase; n is 0, 1, 2, or 3; and at least one of C.
alpha.
or C.
beta.
is in the S configuration.
2.
The monomer of claim 1 wherein C.
alpha.
and C.
beta.
are in the S configuration.
3.
The monomer of claim 1 wherein n is 2.
4.
A peptide nucleic acid monomer having the formula: ##STR6## wherein: B is a naturally or non-naturally ocurring nucleobase; and at least one of C.
alpha.
or C.
beta.
is in the S configuration.
5.
The monomer of claim 4 wherein C.
alpha.
and C.
beta.
are in the S configuration.
6.
A peptide nucleic acid oligomer complementary to a target molecule, said oligomer comprising at least one peptide nucleic acid monomer having a (2-aminoethyl)glycine backbone, wherein the C.
alpha.
and C.
beta.
carbons of said monomer form part of an alicyclic structure which renders said C.
alpha.
and C.
beta.
carbons chiral, said monomer being incorporated into the peptide nucleic acid oligomer at a position corresponding to a region of variability in the target molecule.
7.
An oligomer comprising at least two peptide nucleic acid monomers, at least one of said peptide nucleic acid monomers having the structure: ##STR7## wherein: B is a naturally or non-naturally ocurring nucleobase; at least one of C.
alpha.
or C.
beta.
is in the S configuration; Q is --OH, a carbonyl protecting group, or a covalent bond; I is H, an amino protecting group, or a covalent bond; and n is 0, 1, 2, or 3.
8.
The oligomer of claim 7 wherein C.
alpha.
and C.
beta.
are in the S configuration.
9.
The oligomer of claim 7 wherein n is 2.
10.
A peptide nucleic acid monomer having the formula: ##STR8## wherein: B is adenine, cytosine, guanine, thymine, or uracil; n is 0, 1, 2, or 3; and at least one of C.
alpha.
or C.
beta.
is in the S configuration.
11.
A peptide nucleic acid monomer having the formula: ##STR9## wherein: B is adenine, cytosine, guanine, thymine, or uracil; and at least one of C



Related patents
  Enzymatic DNA molecules
The present invention thus contemplates a synthetic or engineered (i.e., non-naturally-occurring) catalytic DNA molecule (or enzymatic DNA molecule) capable of cleaving ...
  Multigene vectors
The present invention provides a method for preparing HSV vectors. The method comprises co-transfecting a source vector and a mutating cassette together into a ...
  Composition and method for inhibiting platelet aggregation
OF THE INVENTION This invention is provides a method of preventing or treating diseases or conditions associated with platelet aggregation. The method also provides a ...
  Nucleic acid probes
OF THE INVENTION "Derivatizable" nucleotides are nucleotides modified so as to include at the 4-position of a pyrimidine a functional group which can react with a ...
  Assay for antiviral activity using complex of herpesvirus origin of replication and cellular protein
The drawings are first described. FIG. 1 is a diagram of the HSV-1 genome and oriS. FIG. 1A indicates the locations of the three origins of DNA replication and the ...
  Substrate for detection of mammalian 5-C-DNA methyltransferase
OF THE INVENTION "Oligomeric DNA" or ODN, as used herein, means a DNA having from 10 to 75 "purine or pyrimidine bases" connected in a series of nucleotides which are ...
  Vinyl ethers of nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the racemic and diasteromeric mixtures of these isomers which may exist for ...
  Nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the racemic and diasteromeric mixtures of these isomers which may exist for ...
  Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof
To accomplish those objectives, the present invention provides hydrophobic muiticomponent heparin conjugates in which heparin is coupled with macromolecules and ...
  Gas permeable bioreactor and method of use
OF THE PREFERRED EMBODIMENTS Like numbered apparatus elements in FIGS. 1-11 are the same. Referring to the drawings, FIG. 1 is a cross-sectional side view of a ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved